Cohance Lifesciences Ltd

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and with reference to our Results conference call intimation dated August 10 2023 that audio recording of the conference call for the quarter ended June 30 2023 held on Thursday August 10 2023 has been uploaded on the Companys website at https://suvenpharm.com/financial-info/This is for your information and record.